Literature DB >> 26148821

Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey.

H Ishikawa1, N Kawakami1, R C Kessler1.   

Abstract

BACKGROUND: The aim of this study is to estimate the lifetime and 12-month prevalence, severity and treatment of Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) mental disorders in Japan based on the final data set of the World Mental Health Japan Survey conducted in 2002-2006.
METHODS: Face-to-face household interviews of 4130 respondents who were randomly selected from Japanese-speaking residents aged 20 years or older were conducted from 2002 to 2006 in 11 community populations in Japan (overall response rate, 56%). The World Mental Health version of the World Health Organization Composite International Diagnostic Interview (WMH-CIDI), a fully structured, lay administered psychiatric diagnostic interview, was used for diagnostic assessment.
RESULTS: Lifetime/12-month prevalence of any DSM-IV common mental disorders in Japan was estimated to be 20.3/7.6%. Rank-order of four classes of mental disorders was anxiety disorders (8.1/4.9%), substance disorders (7.4/1.0%), mood disorders (6.5/2.3%) and impulse control disorders (2.0/0.7%). The most common individual disorders were alcohol abuse/dependence (7.3/0.9%), major depressive disorder (6.1/2.2%), specific phobia (3.4/2.3%) and generalized anxiety disorder (2.6/1.3%). While the lifetime prevalence of any mental disorder was greater for males and the middle-aged, the persistence (proportion of 12-month cases among lifetime cases) of any mental disorder was greater for females and younger respondents. Among those with any 12-month disorder, 15.3% were classified as severe, 44.1% moderate and 40.6% mild. Although a strong association between severity and service use was found, only 21.9% of respondents with any 12-month disorder sought treatment within the last 12 months; only 37.0% of severe cases received medical care. The mental health specialty sector was the most common resource used in Japan. Although the prevalence of mental disorders were quite low, mental disorders were the second most prevalent cause of severe role impairment among chronic physical and mental disorders.
CONCLUSIONS: These results suggest lower prevalence of mental disorders in Japan than that in Western countries, although the general pattern of disorders, risk factors and unmet need for treatment were similar to those in other countries. Greater lifetime prevalence for males and greater persistence for females seems a unique feature of Japan, suggesting a cultural difference in gender-related etiology and course of disorders. The treatment rate in Japan was lower than that in most other high-income countries in WMH surveys.

Entities:  

Keywords:  Cross-sectional study; epidemiology; health service research; mental health

Mesh:

Year:  2015        PMID: 26148821      PMCID: PMC5144586          DOI: 10.1017/S2045796015000566

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  32 in total

1.  Suicides in Japan reach a record high.

Authors:  J Lamar
Journal:  BMJ       Date:  2000-09-02

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Assessing psychiatric impairment in primary care with the Sheehan Disability Scale.

Authors:  A C Leon; M Olfson; L Portera; L Farber; D V Sheehan
Journal:  Int J Psychiatry Med       Date:  1997       Impact factor: 1.210

4.  Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China.

Authors:  Yu-Cun Shen; Ming-Yuan Zhang; Yue-Qin Huang; Yan-Ling He; Zhao-Rui Liu; Hui Cheng; Adley Tsang; Sing Lee; Ronald C Kessler
Journal:  Psychol Med       Date:  2005-12-07       Impact factor: 7.723

5.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology.

Authors: 
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

6.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

7.  Lifetime and 6-month prevalence of DSM-III-R psychiatric disorders in an urban community in Japan.

Authors:  Norito Kawakami; Hiroyuki Shimizu; Takashi Haratani; Noboru Iwata; Toshinori Kitamura
Journal:  Psychiatry Res       Date:  2004-01-01       Impact factor: 3.222

8.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

9.  Changes in rates of depressive symptoms in a Japanese working population: life-table analysis from a 4-year follow-up study.

Authors:  N Kawakami; R E Roberts; E S Lee; S Araki
Journal:  Psychol Med       Date:  1995-11       Impact factor: 7.723

Review 10.  The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.

Authors:  Zachary Steel; Claire Marnane; Changiz Iranpour; Tien Chey; John W Jackson; Vikram Patel; Derrick Silove
Journal:  Int J Epidemiol       Date:  2014-03-19       Impact factor: 7.196

View more
  36 in total

1.  Low prevalence rates of common mental disorders in Japan: does it still hold true?

Authors:  N Watanabe
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-30       Impact factor: 6.892

2.  Depressive, anxiety and post-traumatic stress disorders at six years after occupational injuries.

Authors:  Wei-Shan Chin; Judith Shu-Chu Shiao; Shih-Cheng Liao; Chun-Ya Kuo; Chih-Chieh Chen; Yue Leon Guo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-01-02       Impact factor: 5.270

3.  Study of blood exposure-related mental health illness among clinical nurses.

Authors:  Xiaojia Xiong; Min Li; Yongliang Jiang; Xindeng Tong; Yanzhong Peng
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 4.  Specific phobias.

Authors:  William W Eaton; O Joseph Bienvenu; Beyon Miloyan
Journal:  Lancet Psychiatry       Date:  2018-08       Impact factor: 27.083

5.  Twelve-month use of herbal medicines as a remedy for mental health problems in Japan: A cross-national analysis of World Mental Health Survey data.

Authors:  Mai Iwanaga; Hiroo Iwanaga; Norito Kawakami
Journal:  Asia Pac Psychiatry       Date:  2017-06-19       Impact factor: 2.538

6.  12-month prevalence and concomitants of DSM-IV depression and anxiety disorders in two violence-prone cities in Brazil.

Authors:  Sergio L Blay; Gerda G Fillenbaum; Marcelo F Mello; Maria I Quintana; Jair J Mari; Rodrigo A Bressan; Sergio B Andreoli
Journal:  J Affect Disord       Date:  2018-02-17       Impact factor: 4.839

7.  Effectiveness of Screening and Brief Alcohol Intervention at the Workplace: A Study Protocol for a Randomized Controlled Trial at Five Japan-Based Companies.

Authors:  Yuki Kuwabara; Aya Kinjo; Maya Fujii; Ruriko Minobe; Hitoshi Maesato; Susumu Higuchi; Hisashi Yoshimoto; Maki Jike; Yuichiro Otsuka; Osamu Itani; Yoshitaka Kaneita; Hideyuki Kanda; Yoneatsu Osaki
Journal:  Yonago Acta Med       Date:  2021-10-02       Impact factor: 1.641

8.  Meta-analysis of the prevalence of anxiety disorders in mainland China from 2000 to 2015.

Authors:  Xiaojing Guo; Zhen Meng; Guifeng Huang; Jingyuan Fan; Wenwen Zhou; Weijun Ling; Juan Jiang; Jianxiong Long; Li Su
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

9.  Utilizing a medical questionnaire to predict anxiety and depression in outpatients.

Authors:  Hideki Kajiwara; Yoshiyuki Ohira; Akiko Ikegami; Nao Hanazawa; Takako Masuyama; Tomoko Yamashita; Takeshi Kondo; Kiyoshi Shikino; Masatomi Ikusaka
Journal:  Int J Gen Med       Date:  2016-06-11

10.  Evaluation of factors associated with psychiatric patient dropout at a university outpatient clinic in Japan.

Authors:  Atsumi Minamisawa; Jin Narumoto; Isao Yokota; Kenji Fukui
Journal:  Patient Prefer Adherence       Date:  2016-09-20       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.